Texas Children's Hospital is a nationally ranked, freestanding 973-bed, acute care women's and children's hospital located in Houston, Texas. It is affiliated with Baylor College of Medicine and is located within the Texas Medical Center.

There are 973 beds in Texas Children's Hospital- Investigational Pharmacy.

During the past decade, Texas Children's Hospital- Investigational Pharmacy conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Texas Children's Hospital- Investigational Pharmacy" are "Juvenile Idiopathic Arthritis" (2 trials). Many other conditions were trialed in "Texas Children's Hospital- Investigational Pharmacy" in a lesser frequency.

Most popular intervention types in "Texas Children's Hospital- Investigational Pharmacy" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CP-690,550 (tofacitinib)" (1 trials), "Tofacitinib" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Texas Children's Hospital- Investigational Pharmacy" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Texas Children's Hospital- Investigational Pharmacy". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Texas Children's Hospital- Investigational Pharmacy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Texas Children's Hospital- Investigational Pharmacy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".